This federal contract award, valued at $128,187.18, was issued by the Defense Logistics Agency (DLA) to Genentech USA, Inc., a foreign-owned, for-profit biotechnology and pharmaceutical manufacturer. The contract is a delivery order under a larger indefinite delivery vehicle with the DLA, valued at $27.9 million, to fulfill orders for medical supplies and critical pharmaceuticals supporting the Department of Defense's global health logistics network.
The specific product being delivered under this award is oseltamivir phosphate, an antiviral medication commonly known as Tamiflu. Genentech is a major supplier of pharmaceuticals and biologics to various federal agencies, including the Department of Defense, Department of Health and Human Services, Department of Justice, and Department of Veterans Affairs. The contract does not have a set-aside designation.